11/15/2025
Exciting news for women’s health! 💜
The FDA has removed the black box warning from low-dose va**nal estrogen, bringing safety labeling in line with the latest science.
These treatments are minimally absorbed and do NOT carry the same risks as oral estrogen. 🙌
Low-dose va**nal estrogen is still one of the most effective treatments for Genitourinary Syndrome of Menopause (GSM), a condition that can cause va**nal dryness, pain with intimacy, irritation, and urinary discomfort.
For women living with GSM, this means:
✅ Greater confidence in care
✅ Easier access to treatment
✅ Better symptom relief
🔗 Learn more about GSM via the Urology Care Foundation:
[LINK] https://www.urologyhealth.org/healthy-living/urologyhealth-extra/current-issue-fall_winter-2025/genitourinary-syndrome-of-menopause-(gsm)